Neumora Therapeutics (NMRA) Announces Leadership Transition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
Neumora Therapeutics Announces Leadership Transition
February 13, 2025 7:00 AM ESTPaul L. Berns, executive chair of Neumora Board of Directors, to serve as chief executive officer and chairman of the Board
Joshua Pinto, Ph.D. to serve as president
Bill Aurora, Pharm.D. to serve as chief operating and development officer; Michael Milligan to serve as chief financial officer
Neumora to host conference call on March 3, 2025 to report its fourth quarter and full year 2024 financial results and provide a business update
WATERTOWN, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq:... More
